News & Insights

Reports
19th July 2022

The CyberScope – Q2 2022

Cybersecurity multiples remain at a higher level than other technology verticals and revenue multiples are trading above pre-COVID 19 levels, whilst M&A volumes and values continue to outpace other sectors – all in spite of widespread depressed public market valuations. With the sector expected to strengthen against the increasing sophistication of hackers, established players continue […]

Reports
19th July 2022

The Enterprise Stack – Q2 2022

The private M&A markets recorded just north of 500 deals for the quarter, a number significantly greater than that recorded in Q2 of 2021 (399), and well above pre-pandemic levels. This quarter further witnessed one of the biggest acquisitions in tech history – Broadcom’s $69Bn acquisition of VMware, as the chipmaker seeks to diversify and […]

Reports
19th July 2022

The Global Technology Market Review – Q2 2022

Private deal activity and valuations within the global technology market remain high in spite of macroeconomic uncertainty. M&A continues to be driven by further adoption of cloud and next-gen technologies, increased focus on strategic tuck-ins, and launching in new markets. As geopolitical uncertainty continues to impact public markets, the outlook for the second half of […]

Insights
5th July 2022

5 Keys to Successfully Raising Series B and Later Rounds for SaaS Companies

Much has already been written regarding raising capital that talks about the need to start a process early, getting your pitch right, and that you should talk to a wide spectrum of investors. Whilst all true, what isn’t as well covered are the specifics of what you need to do to improve your chances of […]

Insights
23rd June 2022

BIO International in San Diego: Sunny with scattered economic clouds

The biopharma universe gathered in San Diego last week for the first face to face BIO International conference in three years. Turn-out was good but below the get-together in Philadelphia in 2019. That one topped out above 17,000 attendees according to the BIO website; whisper numbers this time around were in the region of 12,000. I […]

Events
17th June 2022

Partnering with Private Equity: the Inside Story

Date:
05/07/2022
Venue:
Home House, 20 Portman Square, London W1H 6LW
Time:
8:15 - 10:00
Events
3rd June 2022

BIO International Convention June 13-16, 2022 – San Diego, CA

Date:
13/06/2022
Venue:
San Diego, CA, USA
Insights
25th May 2022

Biotech funding in a risk-off climate – does upstream trouble loom for pharma services providers?

Biotech funding is the key driver of innovation in the pharmaceutical industry and is essential in supporting the healthcare ecosystem. More than 80% of drugs marketed by large pharmaceutical companies were discovered and initially developed by biotechs1. Biotech companies also discovered more than 60% of FDA-approved “priority” drugs, which treat life-threatening conditions and offer significant […]

Insights
24th May 2022

Crossrail opens – a big day for travellers to and workers in London

At CG Results Healthcare we execute transactions around the world, with active projects in North America, Europe and Asia Pacific, so we see ourselves as a global organisation with offices and employees in London and New York, so a blog on transport in London might seem oddly parochial, but the opening of Crossrail, or the […]

Subscribe

We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.

  • This field is for validation purposes and should be left unchanged.